News
Perceptive Discovery, a global leader in molecular and functional imaging research, today announced the launch of the FIBRE (Fibrosis Imaging Biomarker Research & Evaluation) Consortium, a bold ...
The CAR-T Cell Therapy Market is growing rapidly with expanding indications, rising trials, and innovations in solid tumor and autoimmune applications.
Currently, Alphamab trades at a price-to-earnings (P/E) ratio of 44 times, even higher than the 30 times for Henlius Biotech ...
1h
Zacks Investment Research on MSNIs Trending Stock Pfizer Inc. (PFE) a Buy Now?Pfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...
Next Generation Antibody Drug Global Market Report 2025 The Business Research Company's Next-Generation Antibody Drug Global Market Report ...
The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
It is hard to think of a less coherent pair of policies: President Trump’s tax policy encourages the very offshoring that his ...
Many established medical therapies to treat myasthenia gravis remain in use, and newer options are available for patients who ...
StockStory.org on MSN11h
ANI Pharmaceuticals (NASDAQ:ANIP) Q1 Earnings: Leading The Generic Pharmaceuticals PackWrapping up Q1 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including ANI ...
Pfizer investors have seen brighter days—and then the last three years happened. Pfizer's share price has plummeted 51% over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results